Mangoceuticals, Inc. (NASDAQ: MGRX), a company specializing in men's health and wellness through a telemedicine platform, has announced its acquisition of a patent for mushroom-derived health ...

today announced the acquisition of patent number WO 2023/086647 PCT/US2022/049857, for mushroom-derived compositions and methods of treatment. This new addition to MangoRx’s intellectual ...

Shares of Mangoceuticals were trading higher in the after-hours market following news the company acquired a patent for mushroom-derived compositions and methods of treatment. After the bell ...

The acquired patent encompasses nutraceutical compositions derived from functional mushrooms, including well-known varieties such as Cordyceps sinensis, Ganoderma lucidum (Reishi), and Hericium ...

According to industry trends, functional mushrooms have become a cornerstone of this market due to their scientifically validated benefits and versatility in addressing key health concerns. The ...